Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports.

The Firm is evaluating testosterone lawsuits on behalf of men who suffered serious cardiovascular events, allegedly due to their use of Depo-Testosterone and other prescription low testosterone therapies.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Free Case Review
The allegations put forth in this complaint echo those included in dozens of testosterone lawsuits now pending in U.S. courts.

New York, New York (PRWEB) August 22, 2014

Testosterone treatment lawsuits (http://www.testosteronelawsuitclaims.com/) continue to be filed in U.S. courts on behalf of men who allegedly suffered serious cardiovascular events due to their use of prescription low testosterone therapies, Bernstein Liebhard LLP reports. According to court documents, a new claim was filed against Pfizer Inc. on July 31st by a California man who allegedly suffered life-threatening heart issues due to his use of Depo-Testosterone. (Case 2:14-cv-06026)

According to the complaint, which is now pending in U.S. District Court, Central District of California, the then 39-year-old plaintiff began receiving Depo-Testosterone injections in May 2011. He suffered serious heart problems in August 2012, and was diagnosed with acute multiple infarctions, which resulted in prolonged hospitalization. Among other things, the complaint alleges that had Pfizer properly disclosed the cardiovascular risks associated with the testosterone treatment, the Plaintiff would have avoided the risk of injury by either not using the medication at all, or by severely limiting the dosage and length of use, and/or closely monitoring its effects on his health.

“The allegations put forth in this complaint echo those included in dozens of testosterone lawsuits now pending in U.S. courts. Our Firm has also heard from a number of men who claim to have experienced similar heart issues due to their use of low testosterone therapy,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is now evaluating testosterone lawsuits on behalf of men who were allegedly harmed by these medications.

Testosterone Lawsuits
Prescription testosterone therapies are approved to treat low testosterone in men who suffer from the condition due to an underlying medical issue. Medications in this class include:*

  • Axiron
  • AndroDerm
  • AndroGel
  • Bio-T Gel
  • Delatestryl
  • Depo-Testosterone
  • Foresta
  • Striant
  • Testopel
  • Testim

According to court documents, more than 170 testosterone lawsuits have been filed in a federal multidistrict litigation underway in U.S. District Court, Northern District of Illinois, all of which put forth allegations similar to those included in the California case. Like that complaint, those pending in Illinois also accuse the manufacturers of low testosterone therapies of failing to warn doctors and patients about their potential to cause serious heart problems. (In re: Testosterone Replacement Therapy Product Liability Litigation - MDL No. 2545)

Court documents indicate that the litigation involving low testosterone therapy has been growing since January 2014, when the U.S. Food & Drug Administration (FDA) announced that it was investigating cardiovascular risks associated with these drugs. The agency’s review was prompted by two studies which indicated that older men, as well as those with pre-existing heart disease, were more likely to suffer heart attacks, strokes or death if they were using testosterone medications.

Men who allegedly experienced life-threatening heart events due to low testosterone therapy may be entitled to compensation for their injury-related damages, including medical bills, lost wages, pain and suffering, and more. Learn more about filing a testosterone treatment lawsuit by visiting Bernstein Liebhard LLP’s website, or calling the Firm today at 800-511-5092.

*accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchType=BasicSearch&searchTerm=testosterone&Search_Button=Submit, FDA

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs' Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
http://www.testosteronelawsuitclaims.com/
https://plus.google.com/115936073311125306742?rel=author